Acorda Therapeutics, Inc. Skyrocketed
Mon, Oct 17, 2022 at 09:10 PM
Acorda Therapeutics, Inc. (ACOR:NASDAQ) shot up at $0.9, representing a gain of 163.8%. On Mon, Oct 17, 2022, ACOR:NASDAQ touched a New 2-Week High of $0.9. The stock got featured on our News Catalysts scanner on Sun, Oct 16, 2022 at 11:00 PM in the 'MISCELLANEOUS' category. From Mon, Oct 03, 2022, the stock recorded 40.00% Up Days and 54.55% Green Days
About Acorda Therapeutics, Inc. (ACOR:NASDAQ)
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.
Top 10 Gainers:
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 163.82%
- Inpixon (INPX:NASDAQ), 90.59%
- FedNat Holding Company (FNHC:NASDAQ), 60.35%
- Oblong Inc. (OBLG:NASDAQ), 54.38%
- Archaea Energy Inc. Class A (LFG:NYSE), 54.15%
- Babylon Holdings Limited Class A (BBLN:NYSE), 43.73%
- OPAL Fuels Inc. (OPAL:NASDAQ), 40.92%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 39.13%
- Statera Biopharma Inc. (STAB:NASDAQ), 35.22%
- Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ), 32.04%